- Home
- LEXX vs CFSB Comparison
LEXX vs CFSB Comparison
Compare LEXX & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- CFSB
- Stock Information
- Founded
- LEXX 2004
- CFSB 1889
- Country
- LEXX Canada
- CFSB United States
- Employees
- LEXX N/A
- CFSB N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- CFSB Major Banks
- Sector
- LEXX Health Care
- CFSB Finance
- Exchange
- LEXX Nasdaq
- CFSB Nasdaq
- Market Cap
- LEXX 43.5M
- CFSB 44.8M
- IPO Year
- LEXX N/A
- CFSB N/A
- Fundamental
- Price
- LEXX $2.01
- CFSB $6.78
- Analyst Decision
- LEXX Strong Buy
- CFSB
- Analyst Count
- LEXX 2
- CFSB 0
- Target Price
- LEXX $11.00
- CFSB N/A
- AVG Volume (30 Days)
- LEXX 148.5K
- CFSB 4.6K
- Earning Date
- LEXX 01-10-2025
- CFSB 10-29-2024
- Dividend Yield
- LEXX N/A
- CFSB N/A
- EPS Growth
- LEXX N/A
- CFSB N/A
- EPS
- LEXX N/A
- CFSB N/A
- Revenue
- LEXX $411,019.00
- CFSB $7,444,000.00
- Revenue This Year
- LEXX $82.02
- CFSB N/A
- Revenue Next Year
- LEXX $95.09
- CFSB N/A
- P/E Ratio
- LEXX N/A
- CFSB N/A
- Revenue Growth
- LEXX 34.05
- CFSB N/A
- 52 Week Low
- LEXX $1.20
- CFSB $5.85
- 52 Week High
- LEXX $6.85
- CFSB $7.95
- Technical
- Relative Strength Index (RSI)
- LEXX 26.93
- CFSB 50.99
- Support Level
- LEXX $2.20
- CFSB $6.65
- Resistance Level
- LEXX $2.42
- CFSB $6.80
- Average True Range (ATR)
- LEXX 0.19
- CFSB 0.10
- MACD
- LEXX -0.00
- CFSB -0.00
- Stochastic Oscillator
- LEXX 7.27
- CFSB 45.56
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.